Philogen SpA (MIL:PHIL) Ending Cash Position : €12.26 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Ending Cash Position?

Philogen SpA's Ending Cash Position for the quarter that ended in Jun. 2024 was €12.26 Mil.

Philogen SpA's quarterly Ending Cash Position declined from Jun. 2023 (€36.59 Mil) to Dec. 2023 (€15.64 Mil) and declined from Dec. 2023 (€15.64 Mil) to Jun. 2024 (€12.26 Mil).

Philogen SpA's annual Ending Cash Position increased from Dec. 2021 (€8.88 Mil) to Dec. 2022 (€24.44 Mil) but then declined from Dec. 2022 (€24.44 Mil) to Dec. 2023 (€15.64 Mil).

Philogen SpA Ending Cash Position Historical Data

The historical data trend for Philogen SpA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Ending Cash Position Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

11.96

8.88

24.44

15.64

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Ending Cash Position	Get a 7-Day Free Trial				11.47	24.44	36.59	15.64	12.26

Philogen SpA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Philogen SpA's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	24.436	+	-8.801
	=	15.64

Philogen SpA's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	15.635	+	-3.371
	=	12.26

Philogen SpA Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.